MLSS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MLSS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-12-13), Milestone Scientific's share price is $0.81. Milestone Scientific's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $0.09. Hence, Milestone Scientific's Price to Tangible Book Ratio of today is 8.90.
The historical rank and industry rank for Milestone Scientific's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Milestone Scientific's highest Price to Tangible Book Ratio was 312.50. The lowest was 3.33. And the median was 7.31.
A closely related ratio is called PB Ratio. As of today, Milestone Scientific's share price is $0.81. Milestone Scientific's Book Value per Sharefor the quarter that ended in Sep. 2024 was $0.09. Hence, Milestone Scientific's P/B Ratio of today is 8.71.
The historical data trend for Milestone Scientific's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | 51.48 | 8.58 | 8.73 | 3.33 | 6.70 |
Milestone Scientific Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | 9.20 | 6.70 | 6.56 | 6.77 | 10.01 |
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Price-to-Tangible-Book falls into.
Milestone Scientific's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Sep. 2024 ) |
= | 0.81 | / | 0.091 | |
= | 8.90 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Milestone Scientific's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Leonard Osser | director, 10 percent owner, officer: CEO | |
Michael Mcgeehan | director | C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039 |
Peter J Milligan | officer: President | 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102 |
Neal I Goldman | director | 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560 |
Leslie Bernhard | director | C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019 |
Benedetta I Casamento | director | 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932 |
Leonard M Schiller | director | |
Scott L. Kahn | officer: Chief Financial Officer | 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068 |
Giandomenico Trombetta | director, 10 percent owner | CORSO VENEZIA 44, MILAN L6 20121 |
Joseph D'agostino | officer: CFO & COO | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
Jan Adriaan Haverhals | officer: President | 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044 |
Brent W Johnston | officer: President | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039 |
Edward J. Zelnick | director | C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039 |
Daniel S Goldberger | officer: President and CEO | 24 CARPENTER ROAD, CHESTER NY 10918 |
Spa Innovest | director, 10 percent owner, officer: See Remarks | CORSO VENEZIA 44, MILAN L6 20121 |
From GuruFocus
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 05-17-2024
By GuruFocus Research • 08-16-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
By GuruFocus Research • 02-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.